Li Zhou

2.6k total citations
111 papers, 1.1k citations indexed

About

Li Zhou is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Li Zhou has authored 111 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Oncology, 51 papers in Molecular Biology and 23 papers in Immunology. Recurrent topics in Li Zhou's work include Cancer Immunotherapy and Biomarkers (37 papers), Cutaneous Melanoma Detection and Management (30 papers) and CAR-T cell therapy research (28 papers). Li Zhou is often cited by papers focused on Cancer Immunotherapy and Biomarkers (37 papers), Cutaneous Melanoma Detection and Management (30 papers) and CAR-T cell therapy research (28 papers). Li Zhou collaborates with scholars based in China, United States and Ethiopia. Li Zhou's co-authors include Lu Si, Bin Lian, Xue Bai, Xinan Sheng, Xieqiao Yan, Bixia Tang, Chuanliang Cui, Jun Guo, Zhihong Chi and Yan Kong and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Journal of Virology.

In The Last Decade

Li Zhou

102 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Zhou China 20 752 515 269 200 166 111 1.1k
Hong Zheng China 13 569 0.8× 632 1.2× 505 1.9× 104 0.5× 179 1.1× 67 1.4k
Quanli Gao China 18 834 1.1× 652 1.3× 582 2.2× 127 0.6× 159 1.0× 67 1.5k
Yanina Jansen Belgium 15 595 0.8× 345 0.7× 192 0.7× 77 0.4× 221 1.3× 48 887
Miranda Payne United Kingdom 22 823 1.1× 502 1.0× 313 1.2× 100 0.5× 133 0.8× 50 1.3k
Tomoki Yamano Japan 18 540 0.7× 364 0.7× 289 1.1× 145 0.7× 91 0.5× 54 972
Guichao Li China 15 426 0.6× 620 1.2× 231 0.9× 179 0.9× 451 2.7× 44 1.2k
John I. Song United States 16 490 0.7× 494 1.0× 147 0.5× 166 0.8× 256 1.5× 34 1.1k
Alex Chehrazi‐Raffle United States 11 869 1.2× 374 0.7× 461 1.7× 138 0.7× 171 1.0× 64 1.3k
Qingyang Feng China 18 460 0.6× 430 0.8× 202 0.8× 126 0.6× 267 1.6× 58 1.0k

Countries citing papers authored by Li Zhou

Since Specialization
Citations

This map shows the geographic impact of Li Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Zhou more than expected).

Fields of papers citing papers by Li Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Zhou. The network helps show where Li Zhou may publish in the future.

Co-authorship network of co-authors of Li Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Li Zhou. A scholar is included among the top collaborators of Li Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Zhou. Li Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Bixia, Rong Duan, Xieqiao Yan, et al.. (2024). Natural history of bone-only metastasis in renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 42(4). 119.e17–119.e22. 1 indexed citations
2.
3.
4.
Mao, Lili, Jie Dai, Xue Bai, et al.. (2024). Neoadjuvant pembrolizumab and lenvatinib in resectable mucosal melanoma: NeoPlus study update.. Journal of Clinical Oncology. 42(16_suppl). 9580–9580. 2 indexed citations
5.
Lian, Bin, Yue Yang, Baomin Zheng, et al.. (2024). Efficacy and Safety of Postoperative Adjuvant Radiation Therapy in Resected Nasal Cavity and Paranasal Sinus Mucosal Melanoma: A Combined Analysis. International Journal of Radiation Oncology*Biology*Physics. 120(2). 528–536. 2 indexed citations
6.
Lai, Yisheng, et al.. (2023). 68例肛管直肠黏膜黑色素瘤临床病理特征及预后. PubMed Central.
7.
Cui, Chuanliang, Xuan Wang, Bin Lian, et al.. (2022). OrienX010, an oncolytic virus, in patients with unresectable stage IIIC–IV melanoma: a phase Ib study. Journal for ImmunoTherapy of Cancer. 10(4). e004307–e004307. 38 indexed citations
8.
Li, Siming, Xiaowen Wu, Xieqiao Yan, et al.. (2022). Toripalimab plus axitinib in patients with metastatic mucosal melanoma: 3-year survival update and biomarker analysis. Journal for ImmunoTherapy of Cancer. 10(2). e004036–e004036. 33 indexed citations
9.
10.
Lian, Bin, Lu Si, Xinan Sheng, et al.. (2022). Toripalimab (anti-PD-1) versus high-dose interferon-α2b as adjuvant therapy in resected mucosal melanoma: a phase II randomized trial. Annals of Oncology. 33(10). 1061–1070. 27 indexed citations
11.
12.
Zhou, Huiling, et al.. (2022). Epithelial-mesenchymal reprogramming by KLF4-regulated Rictor expression contributes to metastasis of non-small cell lung cancer cells. International Journal of Biological Sciences. 18(13). 4869–4883. 7 indexed citations
13.
Wang, Yang, Bin Lian, Lu Si, et al.. (2022). Cumulative incidence and risk factors of brain metastasis for acral and mucosal melanoma patients with stages I–III. European Journal of Cancer. 175. 196–203. 3 indexed citations
14.
Zhou, Li, Yiqiang Liu, Chuanliang Cui, et al.. (2022). Clinicopathological characteristics and prognosis of metastatic collecting duct carcinoma. Urologic Oncology Seminars and Original Investigations. 40(8). 385.e1–385.e8. 3 indexed citations
15.
Yan, Xieqiao, Xinan Sheng, Zhihong Chi, et al.. (2021). Randomized Phase II Study of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Mucosal Melanoma. Journal of Clinical Oncology. 39(8). 881–889. 36 indexed citations
16.
Fěng, Fang, et al.. (2021). TIPE2 Suppresses Malignancy of Pancreatic Cancer Through Inhibiting TGFβ1 Mediated Signaling Pathway. Frontiers in Oncology. 11. 680985–680985. 8 indexed citations
17.
Tang, Bixia, Xieqiao Yan, Rong Duan, et al.. (2021). Real-world efficacy and safety of axitinib in combination with anti-programmed cell death-1 antibody for advanced mucosal melanoma. European Journal of Cancer. 156. 83–92. 13 indexed citations
18.
Wang, Xuan, Weiran Xu, Zhihong Chi, et al.. (2020). Chemotherapy combined with antiangiogenic drugs as salvage therapy in advanced melanoma patients progressing on PD-1 immunotherapy. Translational Oncology. 14(1). 100949–100949. 10 indexed citations
19.
Sheng, Xinan, Dengfeng Cao, Jianlin Yuan, et al.. (2018). Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study. European Journal of Cancer. 100. 1–7. 37 indexed citations
20.
Bai, Xue, Yan Kong, Zhihong Chi, et al.. (2017). MAPK Pathway and TERT Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 Cases. Clinical Cancer Research. 23(20). 6120–6127. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong Zheng Breakdown of academic impact, for papers by Quanli Gao Breakdown of academic impact, for papers by Yanina Jansen Breakdown of academic impact, for papers by Miranda Payne Breakdown of academic impact, for papers by Tomoki Yamano Breakdown of academic impact, for papers by Guichao Li Breakdown of academic impact, for papers by John I. Song Breakdown of academic impact, for papers by Alex Chehrazi‐Raffle Breakdown of academic impact, for papers by Qingyang Feng
Rankless by CCL
2026